| Jul 11 |
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call
|
| Jul 10 |
Ian T. Clark Joins GoodRx Board of Directors
|
| Jul 10 |
3 Lawsuit-Laden Stocks to Dump Before Problems Multiply
|
| Jun 26 |
GoodRx Launches New "Prescription Cost Tracker" to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
|
| Jun 4 |
The 3 Most Undervalued Under-$10 Stocks to Buy in June 2024
|
| May 30 |
Simon Patterson Joins GoodRx Board of Directors
|
| May 30 |
GoodRx Named One of the 2024 TIME100 Most Influential Companies
|
| May 28 |
GoodRx: Encouraging Profit Stabilization (Rating Upgrade)
|
| May 26 |
Street calls of the week: Upgrades for Micron, Magnite and GoodRx Holdings
|
| May 23 |
RBC Capital raises GoodRx to outperform, cites growth opportunities
|
